Researchers at work in a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg

Chinese cancer drug maker BeiGene drops 5 per cent on Hong Kong debut

Topic |   IPO

TOP PICKS

Researchers at work in a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg
READ FULL ARTICLE